期刊文献+

顺铂对人胃癌细胞系p53及其异构体△133p53蛋白表达的影响 被引量:2

Investigate the Effect and Clinical Significance of the Expression of P53 Dealt with Cisplatin in the Human Gastric Cancer Cell Lines MKN45
下载PDF
导出
摘要 目的探讨顺铂对MKN45胃癌细胞系p53及其异构体△133p53蛋白表达的影响及临床意义。方法 PRMI1640血清培养的MKN45胃癌细胞系分为不同浓度梯度顺铂实验组及未加药物对照组。应用免疫细胞化学法检测p53蛋白表达情况。结果免疫细胞化学结果显示DDP组药物血清作用后,△133p53随着药物浓度增加,表达呈减少趋势,△133p53在胃癌组织中的表达呈负相关关系(P<0.01)。结论在顺铂诱导胃癌细胞系MKN45生长抑制的实验中,△133p53异构体蛋白表现出与野生型p53蛋白相反的趋势,并提示△133p53异构体蛋白本身可以作为肿瘤生物学行为的重要预测因子。 Objective To investigate the effect and clinical significance of the expression of p53 dealt with eisplatin in the human gastric cancer cell lines MKN45. Methods The human gastric cancer cell lines MKN45 was cul- tured by serum PRMI1640. The cells were divided into cisplatin group,which was separated by concentration gradient, and the control group. The expression~ effect of p53 were observed by immunocytochemistry. Results Anti-oncogene p53 location in cytoplasm mainly was obselwed by immunocytochemistry. In DDP group,the expression of p53 reinforced obviously,and there was a positive correlation between cisplatin concentration and the expression strength of p53. There was an ohvious difference of the positive expression rate between control and DDP groups( P 〈 0.01 ). Conclusion The expression of p53 ,deah with the chemotherapeutics cisplatin, reinforce in the human gastric cancer cell lines MKN45. There is an important significance for studying the occurrence and development of gastric cancer.
出处 《潍坊医学院学报》 2014年第1期42-44,47,共4页 Acta Academiae Medicinae Weifang
基金 2010年度山东省优秀中青年科学家科研奖励基金(项目编号:BS2010SW034)
关键词 P53 顺铂 人胃癌细胞MKN45 免疫细胞化学 p53 Cisplatin The human gastric cancer cell lines MKN45 Immunocytoehemistry
  • 相关文献

参考文献3

二级参考文献24

  • 1王同杉,游思洪,葛红梅,陈子庆,丁小健,刘平.凋亡抑制蛋白livin在人胃癌中的表达以及和survivin表达的关系[J].南京医科大学学报(自然科学版),2006,26(1):39-43. 被引量:49
  • 2许东奎,赵平,王成锋,邵永孚,蔺宏伟,田艳涛.残胃癌的临床病理特征及预后分析[J].中华肿瘤杂志,2006,28(11):852-854. 被引量:25
  • 3Ahn HS, Kim JW, Yoo MW, et al. Clinicopathological features and surgical outcomes of patients with remnant gastric cancer after a distal gastrectomy. Ann Surg Oncol, 2008, 15:1632-1639.
  • 4Abe H, Murakami K, Satoh S, et al. Influence of bile reflux and Helicobacter pylofi infection on gastritis in the remnant gastric mucosa after distal gastrectomy. J Gastroenterol, 2005, 40 : 563- 569.
  • 5Kaizaki Y, Hosokawa O, Sakurai S, et al. Epstein-Barr virus- associated gastric carcinoma in the remnant stomach: de novo and metachronous gastric remnant carcinoma. J Gastroenterol, 2005, 40:570-577.
  • 6Firat O, Guler A, Sozbilen M, et al. Gastric remnant cancer: an old problem with novel concerns. Langenbecks Arch Surg, 2009, 394:93-97.
  • 7Ojima T, Iwahashi M, Nakamori M, et al. Clinicopathological chara- cteristics of renmant gastric cancer after a distal gastrectomy. J Gastrointest Surg, 2010, 14:277-281.
  • 8Namikawa T, Kitagawa H, Iwabu J, et al. Tumors arising at previous anastomotic site may have poor prognosis in patients with gastric stump cancer following gastrectomy. J Gastrointest Surg, 2010, 18:329-334.
  • 9Barone C, Landriscina M, Quirino M. Schedule - dependent activity of 5 -fluorouracil and irinotecan combination in the treatment of human colorectal cancer: in vitro evidence and a phase Ⅰ dose - escalating clinical trial[J]. Br J Cancer, 2007,96:21 - 28.
  • 10Nippon Shokakibyo, Gakkai Zasshi. Anti - tumor effect of interferon for hepatocellular carcinoma - from the clinical consideration [ J ]. Cancer,2007,104:654 - 659.

共引文献7

同被引文献66

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部